Skip to main content

previous disabled Page of 5
and
  1. Article

    Open Access

    Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study

    It remains a substantial challenge to balance treatment efficacy and toxicity in geriatric patients with multiple myeloma (MM), primarily due to the dynamic nature of frailty. Here, we conducted a prospective ...

    Yingjie Zhang, **nyue Liang, Weiling Xu, **ngcheng Yi in Journal of Hematology & Oncology (2024)

  2. Article

    Open Access

    Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study

    The combination of immune checkpoint inhibitors and antiangiogenic agents has been effective in treating multiple cancers. This was further explored in an open-label, multicenter phase 2 basket study (NCT04346...

    Shengxiang Ren, Anwen **ong, Jia Yu, **cheng Wang in Cancer Immunology, Immunotherapy (2024)

  3. No Access

    Article

    The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese **gpo population: a comparative study with worldwide populations

    Pharmacogenomics is a facet of personalized medicine that explores how genetic variants affect drug metabolism and adverse drug reactions. Therefore, this study aims to detect distinct pharmacogenomic variatio...

    **aoya Ma, Yujie Li, Xufeng Zang, **** Guo in Cancer Chemotherapy and Pharmacology (2024)

  4. Article

    Open Access

    Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting

    Chimeric antigen receptors (CAR) are engineered fusion proteins that target T-cells to specific surface antigens of tumor cells to generate effective anti-tumor responses. CAR T-cell therapy is playing an incr...

    Wenjie Zhang, Sumei Li, **lan Long, Shufeng **e in Experimental Hematology & Oncology (2024)

  5. Article

    Open Access

    BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report

    BRAF mutations are found in 1–5% of non-small-cell lung cancer (NSCLC), with V600 and non-V600 accounting for approximately 50% each. It has been confirmed that targeted therapy with dabrafenib + trametinib is...

    Lan Jiang, Pirong Yang, Yufeng Liu, Juan Li in Journal of Cancer Research and Clinical On… (2024)

  6. Article

    Open Access

    Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis

    Neurotransmitter-initiated signaling pathway were reported to play an important role in regulating the malignant phenotype of tumor cells. Cancer cells could exhibit a “neural addiction” property and build up ...

    Yan Fu, Keyu Shen, Hao Wang, Shun Wang in Signal Transduction and Targeted Therapy (2024)

  7. Article

    Open Access

    Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines

    Vaccines have proven effective in protecting populations against COVID-19, including the recombinant COVID-19 vaccine (Sf9 cells), the first approved recombinant protein vaccine in China. In this positive-cont...

    Wenxin Luo, Jiadi Gan, Zhu Luo, Shuangqing Li in Signal Transduction and Targeted Therapy (2024)

  8. Article

    Open Access

    Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis

    Non-small cell lung cancers (NSCLC) harboring Human Epidermal Growth Factor Receptor 2 (HER2) mutations represent a distinct subset with unique therapeutic challenges. Although immune checkpoint inhibitors (ICIs)...

    Juguang Zhang, Weizhong Han, Jun Guo in Journal of Cancer Research and Clinical On… (2024)

  9. Article

    Open Access

    Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

    Mengyu Guo, Ming**g Cao, Jiufeng Sun in Signal Transduction and Targeted Therapy (2024)

  10. Article

    Open Access

    Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine

    Mengyu Guo, Ming**g Cao, Jiufeng Sun in Signal Transduction and Targeted Therapy (2023)

  11. Article

    Open Access

    Characteristics of HPV integration in cervical adenocarcinoma and squamous carcinoma

    HPV integration usually occurs in HPV-related cancer, and is the main cause of cancer. But the carcinogenic mechanism of HPV integration is unclear. The study aims to provide a theoretical basis for understand...

    Yuxin Bi, Junbo Hu, Ling Zeng, Gang Chen in Journal of Cancer Research and Clinical On… (2023)

  12. No Access

    Article

    Role and efficacy of capecitabine in the anthracycline-free regimen in breast cancer patients: a systematic review and meta-analysis

    Capecitabine has extensive utilization in the treatment of diverse solid tumors, and its efficacy has been substantiated. Its oral administration and minimal toxicity in clinical practice render it advantageou...

    Sisi Wang, Lufeng Deng, Jiaren Chen in Journal of Cancer Research and Clinical On… (2023)

  13. Article

    Open Access

    A self-supervised classification model for endometrial diseases

    Ultrasound imaging is the preferred method for the early diagnosis of endometrial diseases because of its non-invasive nature, low cost, and real-time imaging features. However, the accurate evaluation of ultr...

    Yun Fang, Yanmin Wei, **aoying Liu in Journal of Cancer Research and Clinical On… (2023)

  14. Article

    Open Access

    The role of cell death in SARS-CoV-2 infection

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), showing high infectiousness, resulted in an ongoing pandemic termed coronavirus disease 2019 (COVID-19). COVID-19 cases often experience acute resp...

    Cui Yuan, Zhenling Ma, Jiufeng **e, Wenqing Li in Signal Transduction and Targeted Therapy (2023)

  15. No Access

    Article

    Prediction of histopathologic grades of myxofibrosarcoma with radiomics based on magnetic resonance imaging

    To develop a radiomics-based model from preoperative magnetic resonance imaging (MRI) for predicting the histopathological grades of myxofibrosarcoma.

    Yubin Yao, Yan Zhao, Lie**g Lu in Journal of Cancer Research and Clinical On… (2023)

  16. Article

    Open Access

    Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance

    Glioma is a lethal brain cancer and lacking effective therapies. Challenges include no effective therapeutic target, intra- and intertumoral heterogeneity, inadequate effective drugs, and an immunosuppressive ...

    Yu’e Liu, Yi Chen, Fei Wang, Jianghua Lin, **ao Tan, Chao Chen in Discover Oncology (2023)

  17. Article

    Open Access

    The role of pyroptosis-related lncRNA risk signature in ovarian cancer prognosis and immune system

    Ovarian cancer is a leading cause of death in females with gynecologic cancers. Pyroptosis is a relatively new discovered programmed cell death that is believed to be associated with inflammation. However, stu...

    Yanling Wu, Lei Liang, Qin Li, Lilu Shu, Peter Wang, Shufeng Huang in Discover Oncology (2023)

  18. No Access

    Article

    Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5

    Serum-derived extracellular vesicles (EVs) have been reported to play an important role in non-small cell lung cancer (NSCLC). The current study sought to explore the effect of serum-EVs delivering m6A methyla...

    Shanshan Shi, Tong Wu, Zechen Ma in Journal of Cancer Research and Clinical On… (2023)

  19. Article

    Open Access

    First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors

    QL1706 (PSB205) is a single bifunctional MabPair (a novel technical platform) product consisting of two engineered monoclonal antibodies (anti-PD-1 IgG4 and anti-CTLA-4 IgG1), with a shorter elimination half-l...

    Yuanyuan Zhao, Yuxiang Ma, Aimin Zang, Ying Cheng in Journal of Hematology & Oncology (2023)

  20. Article

    Open Access

    Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds

    The emergence of adapted variants of the SARS-CoV-2 virus has led to a surge in breakthrough infections worldwide. A recent analysis of immune responses in people who received inactivated vaccines has revealed...

    Zhen Cui, Wenxin Luo, Ruihong Chen, Yalun Li in Signal Transduction and Targeted Therapy (2023)

previous disabled Page of 5